Solitary pulmonary nodules: Meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy

Radiology

Volumn 246, Issue 3, 2008, Pages 772-782

  Cronin, Paul ^a   Dwamena, Ben A ^b,c   Kelly, Aine Marie ^a   Carlos, Ruth C ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEPREOTIDE TC 99M; FLUORODEOXYGLUCOSE F 18; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN; TECHNETIUM COMPLEX;

ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTINGENCY TABLE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DISEASE MODEL; HUMAN; LUNG NODULE; MEDLINE; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; ROC CURVE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; TASK PERFORMANCE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; LUNG COIN LESION; LUNG TUMOR; PREDICTION AND FORECASTING; REGRESSION ANALYSIS;

COIN LESION, PULMONARY; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 40949128250     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2463062148     Document Type: Article

References (61)

1. Cronin P. Thoracic CT. Appl Radiol 2003;32:14-27.
2. Winer-Muram H. The solitary pulmonary nodule. Radiology 2006;239(1):34-49.
3. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987;60(11):2682-2689.
4. Worsley DF, Celler A, Adam MJ, et al. Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography. AJR Am J Roentgenol 1997;168(3):771-774.
5. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285(7):914-924.
6. Blum JE, Handmaker H, Rinne NA. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules. Chest 1999;115(1):224-232.
7. Awaya H, Matsumoto T, Honjo K, Miura G, Emoto T, Matsunaga N. A preliminary study of discrimination among the components of small pulmonary nodules by MR imaging: correlation between MR images and histologic appearance. Radiat Med 2000;18(1):29-38.
8. Khan KS. Systematic reviews of diagnostic tests: a guide to methods and application. Best Pract Res Clin Obstet Gynaecol 2005;19(1):37-46.
9. Deville WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002;2:9.
10. Bachmann LM, Bischof DB, Bischofberger SA, Bonani MG, Osann FM, Steurer J. Systematic quantitative overviews of the literature to determine the value of diagnostic tests for predicting acute appendicitis: study protocol. BMC Surg 2002;2:2.
11. Honest H, Khan KS. Reporting of measures of accuracy in systematic reviews of diagnostic literature. BMC Health Serv Res 2002;2(1):4.
12. Coughlin SS, Trock B, Criqui H, Pickle LW, Browner D, Tefft MC. The logistic modeling of sensitivity, specificity and predictive value of a diagnostic test. J Clin Epidemiol 1992;45(1):1-7.
13. Knottnerus JA. Application of logistic regression to the analysis of diagnostic data: exact modeling of a probability tree of multiple binary variables. Med Decis Making 1992;12(2):93-108.
14. Greiner M, Gardner IA. Epidemiologic issues in the validation of veterinary diagnostic tests. Prev Vet Med 2000;45(1-2):3-22.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560.
16. Wang MC, Bushman BJ. Using normal quantile plots to explore meta-analysis data sets. Psychol Methods 1998;3:46-54.
17. Swensen SJ, Morin RL, Schueler BA, et al. Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material - a preliminary report. Radiology 1992;182(2):343-347.
18. Swensen SJ, Brown LR, Colby TV, Weaver AL. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995;194(2):393-398.
19. Yamashita K, Matsunobe S, Tsuda T, et al. Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT. Radiology 1995;194(2):399-405.
20. Swensen SJ, Brown LR, Colby TV, Weaver AL, Midthun DE. Lung nodule enhancement at CT: prospective findings. Radiology 1996;201(2):447-455.
21. Potente G, Iacari V, Caimi M. The challenge of solitary pulmonary nodules: HRCT evaluation. Comput Med Imaging Graph 1997;21(1):39-46.
22. Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997;205(2):471-478.
23. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214(1):73-80.
24. Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multidetector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 2004;233(1):191-199.
25. Kim JH, Kim HJ, Lee KH, Kim KH, Lee HL. Solitary pulmonary nodules: a comparative study evaluated with contrast-enhanced dynamic MR imaging and CT. J Comput Assist Tomogr 2004;28(6):766-775.
26. Jeong YJ, Lee KS, Jeong SY, et al. Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi- detector row CT. Radiology 2005;237(2):675-683.
27. Hittmair K, Eckersberger F, Klepetko W, Helbich T, Herold CJ. Evaluation of solitary pulmonary nodules with dynamic contrast-enhanced MR imaging: a promising technique. Magn Reson Imaging 1995;13(7):923-933.
28. Guckel C, Schnabel K, Deimling M, Steinbrich W. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology 1996;200(3):681-686.
29. Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management - initial experience. Radiology 2002;224(2):503-511.
30. Schaefer JF, Vollmar J, Schick F, et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging - perfusion differences in malignant and benign lesions. Radiology 2004;232(2):544-553.
31. Tozaki M, Ichiba N, Fukuda K. Dynamic magnetic resonance imaging of solitary pulmonary nodules: utility of kinetic patterns in differential diagnosis. J Comput Assist Tomogr 2005;29(1):13-19.
32. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31(12):1927-1932.
33. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184(2):441-444.
34. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: potential role in evaluation and management. Chest 1993;104(4):997-1002.
35. Patz EF Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188(2):487-490.
36. Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions: a comparative risk-benefit analysis. Chest 1995;108(2):441-446.
37. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995;110(1):130-139.
38. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60(5):1348-1352.
39. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996;37(6):943-948.
40. Bury T, Dowlati A, Paulus P, et al. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J 1996;9(3):410-414.
41. Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997;112(2):416-422.
42. Hagberg RC, Segall GM, Stark P, Burdon TA, Pompili MF. Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography. Eur J Cardiothorac Surg 1997;12(1):92-97.
43. Gupta N, Gill H, Graeber G, Bishop H, Hurst J, Stephens T. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest 1998;114(4):1105-1111.
44. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998;16(3):1075-1084.
45. Orino K, Kawamura M, Hatazawa J, Suzuki I, Sazawa Y. Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDGPET) scans in diagnosis of pulmonary nodules [in Japanese]. Jpn J Thorac Cardiovasc Surg 1998;46(12):1267-1274.
46. Prauer HW, Weber WA, Romer W, Treumann T, Ziegler SI, Schwaiger M. Controlled prospective study of positron emission tomography using the glucose analogue [18f] fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg 1998;85(11):1506-1511.
47. Lee J, Aronchick JM, Alavi A. Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review. Chest 2001;120(6):1791-1797.
48. Higashi K, Ueda Y, Sakuma T, et al. Comparison of [(18)F]FDG PET and (201)TI SPECT in evaluation of pulmonary nodules. J Nucl Med 2001;42(10):1489-1496.
49. Hung GU, Shiau YC, Tsai SC, Ho YJ, Kao CH, Yen RF. Differentiation of radiographically indeterminate solitary pulmonary nodules with. Jpn J Clin Oncol 2001;31(2):51-54.
50. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg 2005;79(3):984-988.
51. Herder GJ, Golding RP, Hoekstra OS, et al. The performance of (18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2004;31(9):1231-1236.
52. Lin WY, Chang GC, Wang SJ. Effectiveness of FDG-PET scans in the evaluation of patients with single pulmonary nodules in Taiwan. Ann Nucl Med Sci 2004;17:63-68.
53. Halley A, Hugentobler A, Icard P, et al. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2005;32(9):1026-1032.
54. Blum J, Handmaker H, Lister-James J, Rinne N. A multicenter trial with a somatostatin analog (99m) Tc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000;117(5):1232-1238.
55. Grewal RK, Dadparvar S, Yu JQ, et al. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules. Cancer J 2002;8(5):400-404.
56. Baath M, Kolbeck KG, Danielsson R. Somatostatin receptor scintigraphy with 99mTc-depreotide (NeoSpect) in discriminating between malignant and benign lesions in the diagnosis of lung cancer: a pilot study. Acta Radiol 2004;45(8):833-839.
57. Kahn D, Menda Y, Kernstine K, et al. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Chest 2004;125(2):494-501.
58. Martins T, Lino JS, Ramos S, Oliveira L. 99mTc-depreotide scintigraphy in the evaluation of indeterminate pulmonary lesions: clinical experience. Cancer Biother Radiopharm 2004;19(2):253-259.
59. Bourguet P; for Groupe de Travail SOR. 2002 standards, options and recommendations for the use of [18F]-FDG (PET-FDG) in cancerology [in French]. Bull Cancer 2003;90(Spec Issue):S1-S109.
60. Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003;93(1):C29-C34.
61. McAuley L, Pham B, Tugwell P, Moher D. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet 2000;356(9237):1228-1231.